Patient Testimonies
Patients: Buy a little stock in Vertex. And tell your stories.
June 8, 2017 Juliana Keeping, Patient Advisor I am in Boston today, a new shareholder in Vertex, the drug maker that could cure my son Eli’s deadly illness, cystic fibrosis. At what cost? So far, the drugs it has developed cost anywhere from $286,000 to $376,000 per year. The company priced our drugs this way […]